COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice
Vaccines against SARS-CoV-2, the causative agent of the COVID-19 pandemic, are urgently needed.